Assessing Drug-Likeness The Natural Compounds of Polar Extract Curcuma xanthorrhiza Rhizome via Lipinski's Rules with SWISSADME Web Tool

Authors

  • Sumardi Sumardi Fakultas Farmasi, Institut Kesehatan Medistra Lubuk Pakam, Indonesia Author
  • Suprianto Suprianto Institut Kesehatan Medistra Lubuk Pakam Author

DOI:

https://doi.org/10.52622/jisk.v5i3.03

Keywords:

polar extract of Curcuma xanthorrhiza rhizoma, Lipinski's Rule of Five, drug-likeness, SWISSADME, permebility prediction

Abstract

Curcuma xanthorrhiza, commonly known as Javanese turmeric, is widely recognized for its medicinal properties, with its polar extract containing various bioactive compounds. This study aims to assess the drug-likeness of natural compounds found in the polar extract of Curcuma xanthorrhiza rhizome using Lipinski's Rule of Five, analyzed through the SWISSADME web tool. The compounds alpha pinene, alpha thujene, beta pinene, and zingiberene were evaluated for their physicochemical properties, including molecular weight, hydrogen bond donors and acceptors, lipophilicity, and solubility. The analysis confirms that these compounds meet the criteria for oral drug-likeness. Additionally, specific parameters such as fractionCsp3, iLOGP, and MLOGP were found to significantly influence the permeability of these compounds, further supporting their potential as orally administered therapeutics. The findings underscore the utility of SWISSADME in preclinical screening of natural products, offering a valuable approach to identify promising candidates for drug development. This study highlights the potential of Curcuma xanthorrhiza polar extract as a source of drug-like compounds, paving the way for further pharmacological and clinical investigations.

Downloads

Download data is not yet available.

References

C. B. Aware et al., “Natural Bioactive Products as Promising Therapeutics: A Review of Natural Product-Based Drug Development,” South African Journal of Botany, vol. 151, pp. 512–528, 2022, doi:10.1016/j.sajb.2022.05.028.

S. T. Devi and K. Sanatombi, “Bioactive Compounds and Biological Activities of Curcuma Species,” in Bioactive Compounds in The Storage Organs of Plants, H. N. Murthy, K. Y. Paek, and S.-Y. Park, Eds., Cham: Springer Nature Switzerland, 2023, pp. 1–57. doi: 10.1007/978-3-031-29006-0_19-1.

“A decade of drug-likeness,” Nat Rev Drug Discov, vol. 6, no. 11, p. 853, 2007, doi: 10.1038/nrd2460.

C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Adv Drug Deliv Rev, vol. 23, no. 1, pp. 3–25, 1997, doi: 10.1016/S0169-409X(96)00423-1.

A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Sci Rep, vol. 7, no. 1, p. 42717, 2017, doi: 10.1038/srep42717.

G. Parmar, A. Shah, S. Shah, and A. K. Seth, “Identification of Bioactive Phytoconstituents from The Plant Euphorbia hirta as Potential Inhibitor of Sars-Cov-2: An In-Silico Approach,” Biointerface Res Appl Chem, vol. 12, no. 2, pp. 1385–1396, 2022, doi: 10.33263/BRIAC122.13851396.

W. R. A. F. Nakrani MN, “Physiology, Glucose Metabolism,” in StatPearls, StatPearls Publishing, 2025, pp. 1–1.

Y.-H. Noh, D.-B. Lee, Y.-W. Lee, and Y.-H. Pyo, “In Vitro Inhibitory Effects of Organic Acids Identified in Commercial Vinegars on α-Amylase and α-Glucosidase,” Prev Nutr Food Sci, vol. 25, no. 3, pp. 319–324, 2020, doi: 10.3746/pnf.2020.25.3.319.

G. K. Jayaprakasha, L. Jaganmohan Rao, and K. K. Sakariah, “Antioxidant Activities of Curcumin, Demethoxycurcumin and Bisdemethoxycurcumin,” Food Chem, vol. 98, no. 4, pp. 720–724, 2006, doi: 10.1016/j.foodchem.2005.06.037.

S. F. Oon et al., “Xanthorrhizol: A Review of Its Pharmacological Activities and Anticancer Properties,” Cancer Cell Int, vol. 15, no. 1, p. 100, 2015, doi: 10.1186/s12935-015-0255-4.

K. Weston-Green, H. Clunas, and C. Jimenez Naranjo, “A Review of The Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health: Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis,” Front Psychiatry, vol. 12, 2021, doi: 10.3389/fpsyt.2021.583211.

A. Simamora, K. H. Timotius, M. B. Yerer, H. Setiawan, and A. Mun’im, “Xanthorrhizol, a Potential Anticancer Agent, from Curcuma xanthorrhiza Roxb,” Phytomedicine, vol. 105, p. 154359, 2022, doi: 10.1016/j.phymed.2022.154359.

M. Talebi et al., “Zingiber officinale ameliorates Alzheimer’s Disease and Cognitive Impairments: Lessons from Preclinical Studies,” Biomedicine & Pharmacotherapy, vol. 133, p. 111088, 2021, doi: 10.1016/j.biopha.2020.111088.

T. C. Reese, A. Devineni, T. Smith, I. Lalami, J.-M. Ahn, and G. V Raj, “Evaluating Physiochemical Properties of FDA-Approved Orally Administered Drugs,” Expert Opin Drug Discov, vol. 19, no. 2, pp. 225–238, Feb. 2024, doi: 10.1080/17460441.2023.2275617.

Downloads

Published

31-12-2024

How to Cite

[1]
S. Sumardi and S. Suprianto , Trans., “Assessing Drug-Likeness The Natural Compounds of Polar Extract Curcuma xanthorrhiza Rhizome via Lipinski’s Rules with SWISSADME Web Tool”, jisk, vol. 5, no. 3, pp. 15–18, Dec. 2024, doi: 10.52622/jisk.v5i3.03.

Similar Articles

11-20 of 35

You may also start an advanced similarity search for this article.